What is the maximum dose of aripiprazole (Abilify) for augmenting an SSRI in adults with major depressive disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Maximum Dose of Aripiprazole for MDD Augmentation

The maximum dose of aripiprazole (Abilify) for augmenting an SSRI in major depressive disorder is 15 mg/day, with a recommended dosage range of 2 to 15 mg/day. 1

FDA-Approved Dosing

According to the FDA label, the specific dosing protocol for aripiprazole as adjunctive treatment in MDD is 1:

  • Starting dose: 2 to 5 mg/day
  • Recommended range: 2 to 15 mg/day
  • Maximum dose: 15 mg/day
  • Dose adjustments: Up to 5 mg/day increments, at intervals of no less than one week

This is notably different from other indications where aripiprazole can be dosed up to 30 mg/day (such as schizophrenia or bipolar disorder).

Evidence Supporting Lower Doses

The FDA dosing is supported by research showing that lower doses may actually be optimal. A 2022 systematic review and dose-effect meta-analysis found that the dose-efficacy curve for aripiprazole augmentation peaked between 2-5 mg/day (OR 1.93 at 5 mg), with a non-increasing trend through higher doses up to 20 mg 2. This suggests that pushing toward the maximum 15 mg dose may not provide additional benefit and could increase side effects.

Multiple clinical trials have demonstrated efficacy across the 2-20 mg range 3, 4, but the dose-response data indicate diminishing returns above 5 mg 2.

Practical Dosing Strategy

Start at 2-5 mg/day and titrate slowly:

  • Begin with 2-5 mg/day added to the existing antidepressant
  • Wait at least one week before increasing
  • Increase in 5 mg increments only if inadequate response
  • Most patients respond adequately at 5-10 mg/day
  • Maximum of 15 mg/day per FDA approval

Common Pitfalls to Avoid

  • Don't exceed 15 mg/day for MDD augmentation - this is the FDA-approved maximum for this indication, even though higher doses are used in other conditions
  • Don't increase too quickly - allow at least one week between dose adjustments to assess response
  • Don't assume higher is better - evidence suggests optimal efficacy occurs at lower doses (2-5 mg), with tolerability concerns increasing at higher doses 2
  • Monitor for akathisia and restlessness - these were the most common adverse effects in MDD augmentation trials, occurring more frequently than with other indications 1

Dose Adjustments for Drug Interactions

If the patient is taking strong CYP3A4 or CYP2D6 inhibitors, reduce the aripiprazole dose by half. If taking both types of inhibitors, reduce to one-quarter of the usual dose 1.

References

Related Questions

What is the best selective serotonin reuptake inhibitor to combine with aripiprazole (Abilify) for treating depression and hallucinations in an 18‑year‑old medication‑naïve patient?
Can aripiprazole be added as augmentation therapy for an adult patient with major depressive disorder who has not achieved adequate improvement after an adequate (≥6 weeks) trial of a therapeutic dose of an SSRI or SNRI?
Is it appropriate to prescribe Abilify (aripiprazole) 30 mg for a patient with treatment‑resistant depression?
Can Abilify (aripiprazole) be co‑prescribed with Lexapro (escitalopram) for depression or anxiety, and what are the recommended starting doses and monitoring parameters?
In a 15-year-old inpatient who has been taking aripiprazole (Abilify) 15 mg daily and sertraline 100 mg daily, with recent non‑compliance and an attempted aripiprazole overdose, what medication changes are recommended?
With a serum creatinine of 0.7 mg/dL indicating normal renal function, do I need to adjust antibiotic dosing if an infection occurs?
Which NSAIDs are safe alternatives for a breastfeeding mother?
What acute and preventive migraine therapies are appropriate for a patient whose rizatriptan (two doses 2 hours apart) failed and who has not received onabotulinumtoxinA (Botox) injections for 22 years?
What anti‑anxiety medication regimen is appropriate for a patient with cerebral palsy who is experiencing anxiety?
What is the recommended next treatment for an adult male with borderline personality disorder who has failed both an SSRI and an SNRI?
Is this follow‑up note appropriate for a 17‑year‑old male with attention‑deficit/hyperactivity disorder (ADHD) and comorbid autism spectrum disorder (ASD) who is currently taking dextroamphetamine‑amphetamine extended‑release 30 mg each morning, dextroamphetamine‑amphetamine immediate‑release 5 mg at noon, and clonidine 0.1 mg twice daily, given the reported modest improvement in focus and impulsivity, good appetite and sleep, no side effects, and ongoing behavioral concerns at school?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.